Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients

Pediatrics International

Volumn 52, Issue 3, 2010, Pages 410-414

  Celebi, Solmaz ^a   Hacimustafaoglu, Mustafa ^a   Koksal, Nilgun ^a   Ozkan, Hilal ^a   Çetinkaya, Merih ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Children; Colistimethate sodium; Nosocomial infection; Pseudomonas aeruginosa

Indexed keywords

COLISTIMETHATE; COLISTIN;

ACINETOBACTER BAUMANNII; ACUTE KIDNEY FAILURE; ADOLESCENT; ARTICLE; BACTERIUM DETECTION; CATHETER INFECTION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; MALE; MORTALITY; NEPHROTOXICITY; NEUROMUSCULAR BLOCKING; NEWBORN; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SEPSIS; SIDE EFFECT; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLISTIN; CROSS INFECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TURKEY;

EID: 77953635339     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2009.03015.x     Document Type: Article

References (27)

1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 1996 9 : 148 165.
2. Livermore D. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? Clin. Infect. Dis. 2002 34 : 634 640.
3. Hamberger H, Diekema D, Fluit A. Surveillance of antibiotic resistance in European ICUs. J. Hosp. Infect. 2001 48 : 161 176.
4. Thamlikitkul V, Jintanothaitavorn D, Sathimethakul R, Vaithayaphicket S, Trakulsomboon S, Danchaivijitr S. Bacterial infections in hospitalized patients in Thailand in 1997 and 2000. J. Med. Assoc. Thai. 2001 84 : 666 673.
5. Catchpole CR, Andrews JM, Brenwald N, Wise R. A reassessment of the in vitro activity of colistin sulphomethate sodium. J. Antimicrob. Chemother. 1997 39 : 255 260.
6. Levin AS, Barone AA, Penço J et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 1999 28 : 1008 1011.
7. Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: Old antibiotics for emerging mutiresistant gram-negative bacteria. Ann. Pharmacother. 1999 33 : 960 967.
8. Hancock RE, Chapple DS. Peptide antibiotics. Antimicrob. Agents Chemother. 1999 43 : 1317 1323.
9. Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez FJ et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: A comparison with imipenem-susceptible VAP. Clin. Infect. Dis. 2003 36 : 1111 1118.
10. Littlewood JM, Koch C, Lambert PA et al. A ten year review of Colomycin. Respir. Med. 2000 94 : 632 640.
11. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, Olsen MA, Fraser VJ. Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: Characteristics, risk factors, and outcomes. Pediatrics 2003 112 : 1283 1289.
12. Lakshmi KS, Jayashree M, Singhi S, Ray P. Study of nosocomial primary bloodstream infections in a pediatric intensive care unit. J. Trop. Pediatr. 2007 53 : 87 92.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am. J. Infect. Control. 1988 16 : 128 140.
14. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth Informational Supplement. M100-S16. Clinical and Laboratory Standards Institute
15. Falagas ME, Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin. Infect. Dis. 2005 40 : 1333 1341.
16. Kaye D. Current use for old antibacterial agent. Infect. Dis. Clin. North Am. 2004 18 : 669 673.
17. Markou N, Apostolakos H, Koumoudiou C et al. Intravenous colistin in the treatment of sepsis from multidrug-resistant Gram-negative bacilli in critically ill patients. Crit. Care 2003 7 : R78 83.
18. Goverman J, Weber JM, Keaney TJ, Sheridan RL. Intravenous colistin for the treatment of multi-drug resistant gram negative infection in the pediatric burn population. J. Burn Care Res. 2007 28 : 421 426.
19. Bouallegue-Godet O, Salem YB, Fabre L, Demartin M, Grimont PAD, Weil FX. Nosocomial outbreak caused by Salmonella enterica serotype livingstone producing CTX-M-27 extended-spectrum β-lactamase in a neonatal unit in Sousse, Tunisia. J. Clin. Microbiol. 2005 43 : 1037 1044.
20. Elward AM, Warren DK, Fraser VJ. Ventilator-associated pneumonia in pediatric intensive care unit patients: Risk factors and outcome. Pediatrics 2002 109 : 758 764.
21. Abramczyk ML, Carvalho WB, Carvalho ES, Medeiros EAS. Nosocomial infection in a pediatric intensive care unit in a developing country. Braz. J. Infect. Dis. 2003 7 : 375 380.
22. Gunderson BW, Ibrahim KH, Hovde LB, Fromm TL, Reed MD, Rotschafer JC. Synergistic activity of colistin and ceftazidime against multiantibiotic- resistant Pseudomonas aeruginosa in an in vitro pharmacologic model. Antimicrob. Agents Chemother. 2003 47 : 905 909.
23. Giamarelos-Bourboulis EJ, Xirouchaki E, Giamarellou H. Interactions of colistin and rifampicin on multidrug-resistant Acinetobacter baumannii. Diagn. Microbiol. Infect. Dis. 2001 40 : 117 120.
24. Yoshikawa TT, Bayer AS, Guze LB. Endocarditis due to Pseudomonas aeruginosa in a heroin addict: Successful treatment with trimethoprim- sulfamethoxazole mixture plus colistin. Chest 1977 72 : 794 796.
25. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman OS. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int. J. Antimicrob. Agents 2006 27 : 224 228.
26. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann. Intern. Med. 1970 72 : 857 868.
27. Lindesmith LA, Baines RD Jr., Bigelow DB, Petty TL. Reversible respiratory paralysis associated with polymyxin therapy. Ann. Intern. Med. 1968 68 : 318 327.